当前位置:主页 > 医学论文 > 外科论文 >

HTK液与高钾停搏液在成人心脏手术中心肌保护效果的荟萃分析

发布时间:2018-05-15 08:34

  本文选题:心肌保护 + HTK液 ; 参考:《华中科技大学学报(医学版)》2017年04期


【摘要】:目的通过比较成人心脏手术中HTK液和高钾停搏液的心肌保护效果,探讨最佳的心肌保护方法。方法检索主要中外生物医学数据库(2005.10~2016.11)文献,收集HTK液与高钾停搏液心肌保护比较的随机对照研究,以Cochrane系统工具评价纳入研究的偏倚风险,对提取的结局指标进行Meta分析。结果最终纳入研究13篇,共含1 047个病例,其中HTK组(实验组)502例,高钾组(对照组)545例;各组研究经检验无统计学异质性,采用固定模型合并。4项研究比较了两组CK-MB峰值,两组的CK-MB峰值无统计学差异(SMD=0.20,95%CI:-0.06~0.46,P=0.21);4项研究比较了两组30d死亡率,两组的30d死亡率无统计学差异(OR=0.53,95%CI:0.22~1.26,P=0.66);6项研究比较了两组自动复跳率,两组的自动复跳率无统计学差异(OR=1.42,95%CI:0.98~2.07,P=0.12)。结论成人心脏手术中,HTK液与高钾停搏液心肌保护效果无差异。
[Abstract]:Objective to compare the myocardial protective effects of HTK solution and hyperkalemia cardioplegia solution in adult cardiac surgery. Methods A randomized controlled study on myocardial protection of HTK solution and hyperkalemic cardioplegia was collected by searching the main Chinese and foreign biomedical databases. The bias risk of the study was evaluated with Cochrane system tool, and the extracted outcome indexes were analyzed by Meta. Results there were 13 studies including 1 047 cases, including HTK group (502 cases) and hyperkalemia group (545 cases). There was no statistical heterogeneity in each group, and the peak value of CK-MB was compared between the two groups by using fixed model combined with 4 items of study. There was no statistical difference in the peak value of CK-MB between the two groups. There was no statistical difference between the two groups in the 30-day mortality rate of the two groups. There was no statistical difference in the 30-day mortality rate between the two groups. The two groups had no statistical difference in the 30-day mortality rate. The rate of automatic rebound was not significantly different between the two groups. There was no statistical difference between the two groups in the rate of automatic rebound. There was no statistical difference between the two groups in the rate of automatic rebound. Conclusion there is no difference in myocardial protection between HTK solution and hyperkalemia cardioplegia in adult cardiac surgery.
【作者单位】: 华中科技大学同济医学院附属同济医院心脏大血管外科;华中科技大学同济医学院附属同济医院药学部;
【分类号】:R654.2

【参考文献】

相关期刊论文 前9条

1 王嵘;高长青;肖苍松;吴扬;王加利;李佳春;骆荩;张涛;马兰;;HTK液与含血心脏停搏液对复杂冠状动脉病变合并左心功能不全心肌保护作用的病例对照研究[J];中国胸心血管外科临床杂志;2016年10期

2 高鲁方;向道康;周涛;张正刚;朱西安;;HTK液对危重症心脏瓣膜病患者瓣膜置换术中的心肌保护作用[J];贵州医药;2015年10期

3 谭今;黄克力;于涛;刘胜中;蒋露;刘科;;温血停搏液和HTK液对二尖瓣手术右心保护作用研究[J];临床外科杂志;2015年09期

4 贺子剑;张力;彭东;钟执文;周成斌;章晓华;范瑞新;庄建;;大血管手术中康斯特保护液与含血停搏液心肌保护效果比较[J];中国体外循环杂志;2014年04期

5 辛梅;赵凯;倪尔连;刘刚;邬晓臣;岳琴;魏晓红;欧阳辉;金振晓;张近宝;;HTK液与含血停搏液用于瓣膜置换联合房颤射频消融治疗患者术中心肌保护的研究[J];中国体外循环杂志;2013年04期

6 张楠;周\娢,

本文编号:1891742


资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/waikelunwen/1891742.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户99e47***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com